Literature DB >> 26884936

The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysis.

Jingyuan Tang1, Xiao Li1, Xuping Jiang2, Weizhang Xu1, Zhen Xu1, Wei Wang1, Bianjiang Liu1, Qiang Lv1, Wei Zhang1.   

Abstract

Previous studies had researched the relationship between rs9642880 gene polymorphism and bladder cancer risk, but the results remained unclear. The comprehensive meta-analysis was performed to clarify this possible association. Relevant articles were searched from Pubmed, Embase and web of science. Odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were calculated to assess the strength of the association. The assessment of publication bias was conducted by Begg's funnel plots and Egger's regression test. A total of 7 casecontrol studies involving 4072 cases and 4898 controls were included in our study. Overall, an obvious relationship between rs9642880 polymorphism and increased risk of bladder cancer were detected in all models. Besides, the positive results were observed among both Caucasians and Asians when stratified by ethnicity. Moreover, when stratified by genotyping method, the significant results were detected in all genotyping methods except Sequenom. In addition, in the subgroup analysis by source of control, significant results were detected in both population and hospital based controls. This present meta-analysis with accurate and reliable results indicated that the T allele of SNP rs9642880 confers susceptibility to bladder cancer in both Asian and Caucasian populations.

Entities:  

Keywords:  MYC; bladder cancer; gene polymorphism; meta-analysis; rs9642880

Year:  2015        PMID: 26884936      PMCID: PMC4723781     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  34 in total

1.  Meta-analysis of genetic association studies.

Authors:  Marcus R Munafò; Jonathan Flint
Journal:  Trends Genet       Date:  2004-09       Impact factor: 11.639

2.  Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?

Authors:  Cristiane Murta-Nascimento; Debra T Silverman; Manolis Kogevinas; Montserrat García-Closas; Nathaniel Rothman; Adonina Tardón; Reina García-Closas; Consol Serra; Alfredo Carrato; Cristina Villanueva; Mustafa Dosemeci; Francisco X Real; Núria Malats
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

3.  Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population.

Authors:  Meilin Wang; Miaomiao Wang; Wei Zhang; Lin Yuan; Guangbo Fu; Qingyi Wei; Zhengdong Zhang
Journal:  Carcinogenesis       Date:  2009-04-15       Impact factor: 4.944

4.  Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity.

Authors:  Outi Hallikas; Kimmo Palin; Natalia Sinjushina; Reetta Rautiainen; Juha Partanen; Esko Ukkonen; Jussi Taipale
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

5.  Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.

Authors:  David R Yates; Morgan Rouprêt; Sarah J Drouin; Marie Audouin; Géraldine Cancel-Tassin; Eva Comperat; Marc-Olivier Bitker; Olivier Cussenot
Journal:  World J Urol       Date:  2012-09-28       Impact factor: 4.226

6.  Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.

Authors:  Markus Aly; Fredrik Wiklund; Jianfeng Xu; William B Isaacs; Martin Eklund; Mauro D'Amato; Jan Adolfsson; Henrik Grönberg
Journal:  Eur Urol       Date:  2011-01-18       Impact factor: 20.096

7.  Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.

Authors:  Carlos E Fonseca-Alves; Marcela M P Rodrigues; Veridiana M B D de Moura; Silvia R Rogatto; Renee Laufer-Amorim
Journal:  Microsc Res Tech       Date:  2013-09-12       Impact factor: 2.769

8.  Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure.

Authors:  Klaus Golka; Matthias Hermes; Silvia Selinski; Meinolf Blaszkewicz; Hermann M Bolt; Gerhard Roth; Holger Dietrich; Hans-Martin Prager; Katja Ickstadt; Jan G Hengstler
Journal:  Pharmacogenet Genomics       Date:  2009-11       Impact factor: 2.089

Review 9.  A comprehensive review of genetic association studies.

Authors:  Joel N Hirschhorn; Kirk Lohmueller; Edward Byrne; Kurt Hirschhorn
Journal:  Genet Med       Date:  2002 Mar-Apr       Impact factor: 8.822

Review 10.  Epidemiology of urinary bladder cancer: from tumor development to patient's death.

Authors:  Cristiane Murta-Nascimento; Bernd J Schmitz-Dräger; Maurice P Zeegers; Gunnar Steineck; Manolis Kogevinas; Francisco X Real; Núria Malats
Journal:  World J Urol       Date:  2007-06       Impact factor: 3.661

View more
  3 in total

1.  CARLo-7-A plausible biomarker for bladder cancer.

Authors:  Hina Amir; Mohammad Azam Khan; Saima Feroz; Nazia Bibi; Muhammad Nawaz; Arshad Mehmood; Arzu Yousuf; Mohammad Athar Khawaja; Muhammad Tahir Khadim; Aamira Tariq
Journal:  Int J Exp Pathol       Date:  2019-03-18       Impact factor: 1.925

2.  Molecular Detection of Genetic Susceptibility to Bladder Cancer in Egyptian Patients.

Authors:  Samah Mamdouh; Fatma Khorshed; Gehan Hammad; Khaled Elesaily; Gehan Safwat; Olfat Hammam; Tarek Aboushousha
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

Review 3.  Association between the ERCC2 Asp312Asn polymorphism and risk of cancer.

Authors:  Feifan Xiao; Jian Pu; Qiongxian Wen; Qin Huang; Qinle Zhang; Birong Huang; Shanshan Huang; Aihua Lan; Yuening Zhang; Jiatong Li; Dong Zhao; Jing Shen; Huayu Wu; Yan He; Hongtao Li; Xiaoli Yang
Journal:  Oncotarget       Date:  2017-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.